From the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
CHEMPHAR is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €130,574 and a net result of €13,101. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 39% of 6,680 sector peers (NACE 64, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
03-04
financial year 2025 · abbreviated format
2025
31-12
Financial
Weakest financial yearnet €13,101 ▼74.8%
Net result drops to €13,101, the lowest in the series.
04-07
financial year 2024 · abbreviated format
2024
31-12
Financial
Highest result from 2022 to 2025net €52,081 ▲74%
Operating result €74,916, net result €52,081, both a record.
31-12
Financial
Equity above €100,000equity €119,139 ▲73.2%
A profit in every financial year since 2022 builds equity to €119,139.
09-07
financial year 2023 · abbreviated format
2023
03-07
financial year 2022 · abbreviated format
2022
09-08
Director discharge · Director appointment
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank